Return
Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns
Z
J
Y
T
C
Y
J
S
S
DOI:10.1016/j.ijmedinf.2026.106542.png)
Abstract
En 中文
• This study developed and validated a Neural Network machine learning model that effectively predicts 5-year recurrence risk in early-stage lung adenocarcinoma patients with high-risk micropapillary or solid pathological patterns, achieving an AUC of 0.775 in the validation set. • Consolidation-to-tumor ratio (CTR) and surgical procedure were identified as the two most important predictive factors, with CTR ≥ 0.5 being the strongest predictor of recurrence. • The model provides clinically actionable insights, suggesting that patients with multiple high-risk factors may benefit from more aggressive treatment strategies despite having early-stage disease.
Journal
IF:
4.1
Papers:
4.5K
Citations:
1.1W
